8 November 2023. Today, UNITE4TB, an international public private partnership striving to fast track the development of innovative Tuberculosis (TB) treatments, announced the start of its phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered.

View this video marking the start of the UNITE4TB phase 2B/C clinical trial program, which kicked off at the trial site in Cape Town, South Africa (copyright: UNITE4TB)